The Patent Finder

Terms ending in 2035

Genmab A/S

Every in-force patent on Genmab A/S's record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,201,607Antibodies Binding Axl
In force
 · High confidence
Genmab A/SIn forceHigh confidence
US 10,500,276Antibodies Binding Axl
In force
 · High confidence
Genmab A/SIn forceHigh confidence
US 10,512,688Antibodies Binding Axl
In force
 · High confidence
Genmab A/SIn forceHigh confidence
US 10,765,743Antibodies Binding Axl
In force
 · High confidence
Genmab A/SIn forceHigh confidence
US 12,115,227Formulation for Antibody and Drug Conjugate Thereof
In force
 · High confidence
Genmab A/SIn forceHigh confidence
US 12,589,150Antibodies Binding Axl
In force
 · Medium confidence
Genmab A/SIn forceMedium confidence
US 9,150,658Human Antibodies Against Tissue Factor and Methods of Use Thereof
In force
 · High confidence
Genmab A/SIn forceHigh confidence
US 10,407,501Humanized or Chimeric CD3 Antibodies
In force
 · High confidence
Genmab A/SIn forceHigh confidence
US 10,465,006Humanized or Chimeric CD3 Antibodies
In force
 · High confidence
Genmab A/SIn forceHigh confidence
US 10,544,220Bispecific Antibodies Against CD3 and CD20
In force
 · High confidence
Genmab A/SIn forceHigh confidence
1 more term end in 2035 · Pro
10 of 11 patents shown. Soonest term end first, then patent number.
Pro members see all 11.
Upgrade to Pro
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited